SCHEMBL14469187

SCHEMBL14469187

C=C(N)/C=C(\C=C/N)CN1CCC(C(=O)N2CCN(Cc3ccc(F)cc3Cl)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ ACHE P22303 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.39
▸ MTNR1B P49286 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD4 P21917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14469186 0.92 ALDH1A1 (0.47) MEN1KMT2AALDH1A1ACHEKDM4E
SCHEMBL14469298 0.91 MEN1 (0.47) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL14469188 0.89 ALDH1A1 (0.46) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL14469170 0.87 KDM4E (0.48) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL14469633 0.85 ALDH1A1 (0.37) MEN1KMT2AALDH1A1CYP3A4ACHE
SCHEMBL14469365 0.84 KDM4E (0.48) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL14469256 0.83 ALDH1A1 (0.38) MEN1KMT2AALDH1A1ACHEKDM4E
SCHEMBL14469577 0.83 KDM4E (0.43) MEN1KMT2ANPC1ALDH1A1KDM4E
SCHEMBL14469573 0.81 MTNR1B (0.39) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL14469292 0.81 ALDH1A1 (0.44) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007075555-A2 COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT SCHERING CORPORATION (US) 2007-07-05 — — WO disclosed
Send feedback